- Canaccord Genuity's Rare Disease Biopharma Day on
February 3, 2015in New York City; and
Leerink Global Healthcare Conferencetaking place in New York Cityon February 11-12, 2015. Will Lewis, President and Chief Executive Officer of Insmed, will participate in a fireside chat with Leerink Partners' analyst, Joseph Schwartz, on February 11, 2015at 11:30 a.m. Eastern time.
Mr. Lewis' fireside chat at the 2015
This release contains forward-looking statements. Words, and variations of words, such as "intend," "expect," "will," "anticipate," "believe," "continue," "propose" and similar expressions are intended to identify forward-looking statements. Investors are cautioned that such statements in this release, including statements relating to the status, results and timing of clinical trials and clinical data, the anticipated benefits of Insmed's products, the anticipated timing of regulatory submissions, and the ability to obtain required regulatory approvals, bring products to market and successfully commercialize products constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, without limitation, failure or delay of European, Canadian,